RIRS With Flex Suction Sheath vs. PCNL for 2-3 cm Renal Stones
A Multicenter, Randomized Controlled Trial Comparing the Retrograde Intrarenal Surgery With a Tip-Flexible Suction Access Sheath to the Standard Percutaneous Nephrolithotomy for the Treatment of 2-3 cm Unilateral Renal Stones
1 other identifier
interventional
308
1 country
1
Brief Summary
This is a multicenter, randomized controlled trial comparing retrograde intrarenal surgery (RIRS) using a tip-flexible suction access sheath with standard percutaneous nephrolithotomy (PCNL) for the treatment of 2-3 cm unilateral renal stones. The aim is to evaluate the clinical efficacy and safety of the novel suction sheath-assisted RIRS compared to standard PCNL in terms of stone-free rate and postoperative complications. A total of 308 patients will be enrolled across four centers in China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 28, 2025
CompletedFirst Posted
Study publicly available on registry
July 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedJuly 10, 2025
April 1, 2025
1.1 years
May 28, 2025
July 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stone-Free Rate (SFR)
The proportion of participants who are stone-free after the procedure, defined as no residual stones or residual fragments \<2 mm based on postoperative plain abdominal X-ray or non-contrast CT scan.
3 months postoperatively
Secondary Outcomes (1)
Incidence of Postoperative Infection (SIRS Criteria)
Within 72 hours postoperatively
Study Arms (2)
Retrograde Intrarenal Surgery (RIRS) with Tip-Flexible Suction Access Sheath
EXPERIMENTALParticipants in this group will undergo retrograde intrarenal surgery (RIRS) using a tip-flexible suction access sheath for the treatment of 2-3 cm unilateral renal stones.
Standard Percutaneous Nephrolithotomy (PCNL)
EXPERIMENTALParticipants in this group will undergo standard percutaneous nephrolithotomy (PCNL) for the treatment of 2-3 cm unilateral renal stones.
Interventions
Participants undergo retrograde intrarenal surgery (RIRS) using a tip-flexible suction access sheath. The procedure involves the insertion of a flexible ureteroscope through the urethra and ureter into the kidney. A novel access sheath with tip-flexible and suction capabilities is used to facilitate stone fragmentation and removal. The goal is to improve stone clearance and reduce intrarenal pressure during the procedure.
Participants undergo standard percutaneous nephrolithotomy (PCNL). The procedure involves creating a percutaneous tract into the renal collecting system under imaging guidance, followed by nephroscope insertion to fragment and extract 2-3 cm renal stones. This represents the current standard of care for large renal calculi.
Eligibility Criteria
You may qualify if:
- Age between 18 and 80 years
- American Society of Anesthesiologists (ASA) physical status classification of I-III
- Single renal stone with a diameter between 2-3 cm confirmed by non-contrast CT scan
- Signed written informed consent and willingness to comply with study procedures
You may not qualify if:
- Anatomical abnormalities of the urinary tract (e.g., horseshoe kidney, ileal conduit)
- Uncontrolled urinary tract infection
- Absolute contraindications for RIRS or PCNL
- Inability to understand or complete study documentation
- Failure to follow study protocol or attend follow-up
- Patients requiring urgent rescue or at high risk for irreversible harm during surgery
- Patients who voluntarily withdraw from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Changhai Hospitallead
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicinecollaborator
- Zhejiang Provincial People's Hospitalcollaborator
- Affiliated Hospital of Jiaxing Universitycollaborator
Study Sites (1)
Changhai Hospital, Naval Medical University
Shanghai, Shanghai Municipality, 200433, China
Related Publications (2)
Skolarikos A, Jung H, Neisius A, et al. EAU Guidelines on Urolithiasis 2024. European Association of Urology. https://uroweb.org/guidelines/urolithiasis
BACKGROUNDZeng G, Traxer O, Zhong W, Osther P, Pearle MS, Preminger GM, Mazzon G, Seitz C, Geavlete P, Fiori C, Ghani KR, Chew BH, Git KA, Vicentini FC, Papatsoris A, Brehmer M, Martinez JL, Cheng J, Cheng F, Gao X, Gadzhiev N, Pietropaolo A, Proietti S, Ye Z, Sarica K. International Alliance of Urolithiasis guideline on retrograde intrarenal surgery. BJU Int. 2023 Feb;131(2):153-164. doi: 10.1111/bju.15836. Epub 2022 Jul 12.
PMID: 35733358BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2025
First Posted
July 10, 2025
Study Start
April 1, 2025
Primary Completion
April 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
July 10, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share